BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37140088)

  • 1. Skin cancer incidence in transgender individuals receiving gender-affirming hormone treatment: a nationwide cohort study in the Netherlands.
    Rahmat A; De Nie I; Wiepjes CM; Den Heijer M; Rustemeyer T; De Blok CJM; Dreijerink KMA
    Int J Dermatol; 2023 Jul; 62(7):882-887. PubMed ID: 37140088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment.
    de Nie I; de Blok CJM; van der Sluis TM; Barbé E; Pigot GLS; Wiepjes CM; Nota NM; van Mello NM; Valkenburg NE; Huirne J; Gooren LJG; van Moorselaar RJA; Dreijerink KMA; den Heijer M
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3293-9. PubMed ID: 32594155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
    de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
    BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands.
    van der Loos MATC; Hannema SE; Klink DT; den Heijer M; Wiepjes CM
    Lancet Child Adolesc Health; 2022 Dec; 6(12):869-875. PubMed ID: 36273487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy.
    Karalexi MA; Frisell T; Cnattingius S; Holmberg D; Holmberg M; Kollia N; Skalkidou A; Papadopoulos FC
    Eur J Prev Cardiol; 2022 Nov; 29(15):2017-2026. PubMed ID: 35778824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fracture Risk in Trans Women and Trans Men Using Long-Term Gender-Affirming Hormonal Treatment: A Nationwide Cohort Study.
    Wiepjes CM; de Blok CJ; Staphorsius AS; Nota NM; Vlot MC; de Jongh RT; den Heijer M
    J Bone Miner Res; 2020 Jan; 35(1):64-70. PubMed ID: 31487065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study.
    de Nie I; Wiepjes CM; de Blok CJM; van Moorselaar RJA; Pigot GLS; van der Sluis TM; Barbé E; van der Voorn P; van Mello NM; Huirne J; den Heijer M
    BJU Int; 2022 Apr; 129(4):491-497. PubMed ID: 34390620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
    Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
    BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
    Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
    Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy.
    van Velzen D; Wiepjes C; Nota N; van Raalte D; de Mutsert R; Simsek S; den Heijer M
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2000-e2007. PubMed ID: 34971391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy.
    Silva ED; Fighera TM; Allgayer RM; Lobato MIR; Spritzer PM
    Front Psychiatry; 2021; 12():621075. PubMed ID: 34381383
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons.
    Morssinkhof MWL; Wiepjes CM; Bosman BW; Kinds J; Fisher AD; Greenman Y; Kreukels BPC; T'Sjoen G; van der Werf YD; Heijer MD; Broekman BFP
    Sleep Med; 2023 Jul; 107():316-326. PubMed ID: 37271109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
    Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
    Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study.
    Gao JL; Sanz J; Tan N; King DS; Modest AM; Dommasch ED
    J Am Acad Dermatol; 2023 Sep; 89(3):504-510. PubMed ID: 36780950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
    Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
    Suppakitjanusant P; Ji Y; Stevenson MO; Chantrapanichkul P; Sineath RC; Goodman M; Alvarez JA; Tangpricha V
    J Clin Transl Endocrinol; 2020 Sep; 21():100230. PubMed ID: 32685379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria.
    de Blok CJ; Wiepjes CM; van Velzen DM; Staphorsius AS; Nota NM; Gooren LJ; Kreukels BP; den Heijer M
    Lancet Diabetes Endocrinol; 2021 Oct; 9(10):663-670. PubMed ID: 34481559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women.
    de Nie I; van Mello NM; Vlahakis E; Cooper C; Peri A; den Heijer M; Meißner A; Huirne J; Pang KC
    Cell Rep Med; 2023 Jan; 4(1):100858. PubMed ID: 36652919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.